Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXD2DK
|
||||
| Drug Name |
(R)-4-(3,4-Difluoro-phenyl)-2-methyl-6-oxo-1,4,5,6-tetrahydro-pyridine-3-carboxylic acid {3-[4-cyano-4-(2-cyano-phenyl)-piperidin-1-yl]-propyl}-amide
|
||||
| Synonyms |
CHEMBL44042
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C29H29F2N5O2
|
||||
| Canonical SMILES |
CC1=C([C@H](CC(=O)N1)c2ccc(F)c(F)c2)C(=O)NCCCN3CCC(CC3)(C#N)c4ccccc4C#N
|
||||
| InChI |
InChI=1S/C29H29F2N5O2/c1-19-27(22(16-26(37)35-19)20-7-8-24(30)25(31)15-20)28(38)34-11-4-12-36-13-9-29(18-33,10-14-36)23-6-3-2-5-21(23)17-32/h2-3,5-8,15,22H,4,9-14,16H2,1H3,(H,34,38)(H,35,37)/t22-/m1/s1
|
||||
| InChIKey |
ZJHCRGOBWWAXOV-JOCHJYFZSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Alpha-1 adrenergic receptor | Target Info | [1587926] | ||
| Histamine H1 receptor | Target Info | [1587926] | |||
| PANTHER Pathway | Histamine H1 receptor mediated signaling pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.